Developing a lateral flow device for the detection of novel breast cancer biomarkers

dc.contributor.advisorMeyer, M
dc.contributor.authorTejada, Aaron
dc.date.accessioned2023-05-17T14:04:40Z
dc.date.accessioned2024-05-09T07:45:25Z
dc.date.available2023-05-17T14:04:40Z
dc.date.available2024-05-09T07:45:25Z
dc.date.issued2023
dc.descriptionMasters of Scienceen_US
dc.description.abstractBreast cancer is the most prevalent malignancy and one of the leading causes of death in women worldwide. Delayed diagnosis of breast cancer greatly reduces the effectiveness of treatment and is considered one of the major contributing factors to its high mortality rate. Cancer treatment is most effective during the early stages of the disease, therefore the earlier that cancer is detected, the greater the chance for survival. Currently, breast cancer screening relies largely on imaging techniques such as mammography and magnetic resonance imaging (MRI) which lack sensitivity and specificity; and are both invasive, cost-intensive and are often not easily accessible to patients in low-income countries.en_US
dc.identifier.urihttps://hdl.handle.net/10566/13328
dc.language.isoenen_US
dc.publisherUniversity of the Western Capeen_US
dc.rights.holderUniversity of the Western Capeen_US
dc.subjectBiomarkersen_US
dc.subjectBreast canceren_US
dc.subjectCervical canceren_US
dc.subjectDiagnosticen_US
dc.subjectGold nanoparticlesen_US
dc.titleDeveloping a lateral flow device for the detection of novel breast cancer biomarkersen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Tejada_nsc_m_2023.pdf
Size:
26.5 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description: